Symetrian™ is a standardized, patent pending, Aloe-based composition for a healthy immune homeostasis.* It is clinically proven to promote rapid immune cell activation and production of circulating TCRγδ+ Gamma delta T cells, suggestive of its heightened immune surveillance at portals of entry, providing immediate immune response.*
Symetrian™ has also been clinically proven to increase the levels of glutathione peroxidase (GSH-Px) highlighting its strong antioxidant activity.* Symetrian™ is composed of plant extracts standardized for speciﬁc polysaccharides and polyphenols from three botanicals with a long history of safe human consumption for immune support, Aloe barbadensis (Aloe vera), Poria cocos and Rosemary (Rosmarinus officinalis).
What Makes Symetrian™ Unique?
Standardized, patent-pending, novel Aloe-based composition with long history of safe human consumption for immune support*
Suitable as a long-term daily supplement for all populations.
Extensive scientific evidence including two randomized, double-blind placebo-controlled, IRB approved clinical studies
Clinically proven to support maintenance of healthy immunity homeostasis*
Clinically proven to support cellular and humoral immunity by increasing TCRγδ+ Gamma delta T cells and IgG antibodies*
Clinically proven to support healthy inflammatory response by maintaining healthy cytokine levels and cytokine responses*
Clinically proven to support strong antioxidant activity*
Clinically proven to support rapid immune activation and response*
Clinically proven to activate Natural killer cells and Gamma delta T cells within hours*
Derived from Aloe vera, Poria cocos, and Rosemary extracts.
Maintenance of immunity homeostasis*
Provide heightened mucosal immunity at the portal of entry for increased immune surveillance and/or a robust response*
Promote innate and adaptive immunity*
Provide strong antioxidant activity*
Can be used as an active agent alone or formulated with other cold/flu agents in tablets, capsules, gummi, gels, liquids, powders, bars and other delivery systems.
*Indications and claims related to the health benefits or property of an ingredient or product are intended for industry only and are governed in accordance with country-specific laws and regulations and may not be appropriate for final consumer products. In the United States, it is your responsibility to ensure that product claims and indications are in compliance with all applicable laws and regulations, including the Federal FD&C Act and the FTC Act. In all other countries, please consult with a local regulatory or legal professional who may provide you with competent advice and guidance.
Science & Discovery
Symetrian™’s unique formulation was developed through Unigen’s proprietary Phytologix® technology platform, based on a collection of more than 12,000 plants and marine samples with documented human consumption. Unigen scientists used this library of comprehensive botanical profiles to identify plants that delivered immune support benefits.
This is the first instance of historically safe medicinal plants, Aloe barbadensis (Aloe vera), Poria cocos and Rosmarinus officinalis (Rosemary) being standardized in such a way to achieve immune homeostasis. The actives in these botanical extracts contribute clinically meaningful mechanisms of action to provide Symetrian™ its immune modulation characteristic, suggesting its usage for continual immune readiness and surveillance purposes.
Mechanism of Action
Immune homeostasis and/or immune stimulation and modulation of Symetrian™ is derived from:
Support of the body’s innate immunity
Promotion of the body’s natural adaptive immunity
Support of the body’s natural responses to inflammation and oxidative stress
Pre-Clinical Data on Acute Lung Injury and Inﬂammaging Induced Immune Senescence
Symetrian™ protected animals from Lipopolysaccharide (LPS)-induced sepsis (Figure 2)
Symetrian™ supported health of lungs (Figure 3) in LPS-induced acute lung model, with reduction of key cytokines, chemokines (TNF-α, IL-6, IL-1, CRP, CINC-3)
Symetrian™ increased survival rate in hyperoxia-induced oxidative stress mouse model (Figure 4)
Symetrian™ decreased bacterial load in the broncho-alveolar lavage in hyperoxia-induced oxidative stress mouse model, highlighting its ability in clearing airway bacteria in the lung (Figure 5)
Symetrian™ supported the body’s natural response to protect thymus against oxidative stress-induced immune senescence, which may affect the body’s ability to mount an immune response (Figure 6)
Symetrian™ supported increased SOD activity and increased anti-oxidative protein NRF2, indicating an increased capacity to neutralize free radicals (Figure 7 & 8)
Symetrian™ supported increased CD3+ T-cells, CD4+ helper T-cell, CD8+ Cytotoxic T cells, NKp46+ Natural Killer cells, CD4+TCRγδ+ Gamma delta T cell levels, IgA, demonstrating that the composition primes the immune system and causes expansion of innate and adaptive immune cell populations (Figure 9)
Clinical Data on Immune Support
Supplementation with Symetrian™ 500 mg twice per day was found to increase expansion of Gamma Delta (γδ) T Cells (Figure 10) suggesting a more robust mucosal cellular response highlighting its primarily role in first line of defense and immune surveillance
Symetrian™ supplementation showed statistically significant increase in influenza B-specific IgG levels, in the post-vaccination period indicating enhanced support of humoral protective immunity
Symetrian™ supplementation produced statistically significant increase in the level of serum IL-1RA, indicating its property maintaining healthy cytokine response
The results of this randomized, triple-blind, placebo-controlled study indicated that supplementation with Symetrian™ at 500 mg twice per day significantly supported heightened immune surveillance as a result of expansion of the Gamma delta T-cells compared to placebo. Through the course of the supplementation, subjects who were given Symetrian™ showed a gradual increase in the level of these T cells, moving from day 28 to day 56, where Symetrian™ showed 21.5% and 24.5% increase in the percent of TCRγδ+ cells populations at days 28 and 56 post supplementation, respectively.
In contrast, the placebo group showed decreases in this cell population at the same time frame where 10.5% and 5.6% reduction in the percent of TCRγδ+ cells were observed at days 28 and 56 post supplementation, respectively. Compared to placebo, subjects who received Symetrian™ showed 23.5% and 38.9% increases in the percent of TCRγδ+ cells populations at days 28 and 56 post supplementation, respectively.
Clinical Data on Rapid Immune Modulation
Supplementation with Symetrian™ at 500 mg single oral dose showed rapid immune activation and proliferation in a randomized double-blind placebo-controlled cross over human clinical study
Supplementation with Symetrian™ showed progressive activation in the numbers of lymphocytes (NKT cells, NK cells; cytotoxic T cells, γδT cells) over a 3-hour period in the blood where the percent changes were found statistically significant against placebo on the 3rd hour
Supplementation with Symetrian™ increased activation markers (CD25, CD69 and CD56) on innate and adaptive immune cell populations (monocytes, NK cells, NKT cells, and γδT cells) as early as 1 hour post 500 mg oral supplementation. The CD25 increase after 1 hour and 2 hours was statistically significant for the NKT cells and γδT cells, respectively
Collectively, rapid activation of NKT cells and γδ+ T cells, expansion of γδ+ T cell, monocyte and lymphocyte populations for immediate mucosal response and immune surveillance, increased Influenza B-specific IgG antibodies for boosted immune response, augmented GSH-Px activity for a better equipped antioxidation capacity and enhanced healthy cytokine responses as a result of increased level of IL1-RA, suggest the beneficial use of Symetrian™ for a healthy immune support and balanced response for immune homeostasis.
Safety is a top priority at Unigen. All the ingredients we develop undergo rigorous safety testing using state-of-the-art in vitro, pre-clinical, and/or human safety studies (for some ingredients). Symetrian™ was found safe through these stringent safety studies.*
Beyer WE, Van der Logt JT, van Beek R, Masurel N. Immunoglobulin G, A, and M response to influenza vaccination in di erent age groups: e ects of priming and boosting. J Hyg (Lond). 1986 Jun;96(3):513-522.
Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018 Jan;281(1):8-27.
Sabbaghi A, Miri SM, Keshavarz M, Mahooti M, Zebardast A, Ghaemi A. Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches. Virology Journal 2020;17(1):174. doi: 10.1186/s12985-020-01449-0.
Swarup V, Ghosh J, Ghosh S, Saxena A, Basu A. Antiviral and anti-inflammatory e ects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother. 2007 Sep;51(9):3367-70.
Novak M, Vetvicka V. Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol. 2008 Jan;5(1):47-5
Lee, J.K.; Lee, M.K.; Yun, Y.P.; Kim, Y.; Kim, J.S.; Kim, Y.S.; Kim, K.; Han, S.S.; Lee, C.K. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int. Immunopharmacol. 2001, 1, 1275–1284
Stuart, R.W.; Lefkowitz, D.L.; Lincoln, J.A.; Howard, K.; Gelderman, M.P.; Lefkowitz, S.S. Upregulation of phagocytosis and candidicidal activity of macrophages exposed to the immunostimulant acemannan. Int. J. Immunopharmacol. 1997, 19, 75–82
Sierra-Garcia GD, Castro-Rios R, Gonzalez-Horta A, Lara-Arias J, Chavez-Montes A. Acemannan, an Extracted Polysaccharide from Aloe vera:A Literature Review. Nat Prod Commun. 2014;9:1217–21.
Choi S, Chung MH. A Review on the Relationship between Aloe vera Components and their Biologic E ects. Semin Integr Med. 2003;1:53–62. 10. Bulut O, Kilic G, Domínguez-Andrés J, Netea MG. Overcoming immune dysfunction in the elderly: trained immunity as a novel approach. Int Immunol. 2020 Nov 23:32 (12): 741
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. These statements are presented for informational purposes only and are not intended to be presented to ﬁnal consumers.